- Strategic collaboration agreement with Curetis subsidiary Ares Genetics to develop digital platform for development and life-cycle management of antibiotics
- Program will combine established microbiology laboratory techniques with advanced bioinformatics and AI methods
- Short-term focus on repurposing existing antibiotics to treat infections involving multi-drug-resistant pathogens
Holzkirchen, December 18, 2018 – Sandoz today announces the signature of a strategic collaboration agreement with Ares Genetics GmbH, to …